- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- (S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chro
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride
| EU orphan designation number: | EU/3/14/1336
|
| Active ingredient: | (S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride |
| Indication: | Treatment of Leigh syndrome |
| Sponsor: | Khondrion BV
Philips van Leydenlaan 15, 6525 EX Nijmegen, Nederland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 17/10/2014 | Orphan designation | EMA/OD/068/14 | (2014)7635 of 15/10/2014 |
CONTACT
EU links
Directorate General Health & Consumers